Hint | Réponse | % Correct |
---|---|---|
chloramphénicol | phénicol | 100%
|
spiramycine | macrolide | 50%
|
erythromycine | macrolide | 50%
|
florfénicole | phénicol | 50%
|
céfopérazone | céphalosporine 3G | 33%
|
oxacilline | pénicilline M | 33%
|
doxycycline | tétracycline | 33%
|
cefquinome | céphalosporine 4G | 25%
|
oxytétracycline | tétracycline | 20%
|
spectinomycine | aminocyclitol | 0%
|
dihydrostreptomycine | aminocyclitol | 0%
|
paromomycine | aminocyclitol | 0%
|
framycétine | aminocyclitol | 0%
|
neomycine | aminocyclitol | 0%
|
gentamicine | aminocyclitol | 0%
|
apramycine | aminocyclitol | 0%
|
kanamycine | aminocyclitol | 0%
|
streptomycine | aminocyclitol | 0%
|
céfalexine | céphalosporine 1G | 0%
|
céfapirine | céphalosporine 1G | 0%
|
céfazoline | céphalosporine 1G | 0%
|
céfalonium | céphalosporine 1G | 0%
|
céfovécine | céphalosporine 3G | 0%
|
ceftiofur | céphalosporine 3G | 0%
|
triméthoprime | diaminopyrimidine | 0%
|
lincomysine | lincosamide | 0%
|
clindamycine | lincosamide | 0%
|
pirlimycine | lincosamide | 0%
|
tulathromycine | macrolide | 0%
|
tylvalosine | macrolide | 0%
|
gamithromycine | macrolide | 0%
|
tylosine | macrolide | 0%
|
tilmicosine | macrolide | 0%
|
tildipirosine | macrolide | 0%
|
ampicilline | pénicilline A | 0%
|
amoxicilline | pénicilline A | 0%
|
pénéthamate | pénicilline G | 0%
|
cloxacilline | pénicilline M | 0%
|
nafcilline | pénicilline M | 0%
|
thiamphénicol | phénicol | 0%
|
bacitracine | polypeptide | 0%
|
polymyxine B | polypeptide | 0%
|
colistine | polypeptide | 0%
|
acide oxolinique | quinolone 1G | 0%
|
fluméquine | quinolone 2G | 0%
|
enrofloxacine | quinolone 3G | 0%
|
marbofloxacine | quinolone 3G | 0%
|
danofloxacine | quinolone 3G | 0%
|
orbifloxacine | quinolone 3G | 0%
|
pradofloxacine | quinolone 4G | 0%
|
sulfaguanidine | sulfonamide | 0%
|
sulfadimidine | sulfonamide | 0%
|
sulfaméthoxypyridazine | sulfonamide | 0%
|
chlortétracycline | tétracycline | 0%
|
Copyright H Brothers Inc., 2008–2024
Nous contacter | Retour en haut de page | Passer à la version mobile